Case report: Highly active antiretroviral therapy as the sole treatment for AIDS-related primary central nervous system lymphoma: A case report with implications for treatment

AIDS Patient Care and STDs

Volumn 21, Issue 12, 2007, Pages 900-907

  Aboulafia, David M ^a,b   Puswella, Amal L ^a  

^a VIRGINIA MASON MEDICAL CENTER   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CORTICOSTEROID; LAMIVUDINE; LOPINAVIR PLUS RITONAVIR; STAVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BRAIN BIOPSY; BRAIN RADIATION; BRAIN VENTRICLE PERITONEUM SHUNT; CASE REPORT; CD4 LYMPHOCYTE COUNT; COGNITIVE DEFECT; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTOPATHOLOGY; HUMAN; HYDROCEPHALUS; MALE; NEUROIMAGING; PNEUMOCYSTIS PNEUMONIA; PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA; REMISSION; VIRUS LOAD; B CELL LYMPHOMA; CENTRAL NERVOUS SYSTEM TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; RADIOGRAPHY;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CENTRAL NERVOUS SYSTEM NEOPLASMS; HUMANS; LYMPHOMA, AIDS-RELATED; MAGNETIC RESONANCE IMAGING; MALE;

EID: 37549034686     PISSN: 10872914     EISSN: None     Source Type: Journal    
DOI: 10.1089/apc.2007.0009     Document Type: Article

References (22)

1. Skiest DJ, Crosby C. Survival is prolonged by highly active antiretroviral therapy in AIDS patients with primary central nervous system lymphoma. AIDS 2003;17:1787-1793.
2. Raez LE, Patel P, Feun L, et al. Natural history and prognostic factors for survival in patients with acquired immune deficiency syndrome (AIDS)-related primary nervous system lymphoma (PCNSL). Crit Rev Oncol 1998; 9:199-208.
3. Kasamon YL, Ambinder RF. AIDS_related primary central nervous system lymphoma. Hematol Oncol Clin North Am 2005;19:665-687.
4. Chamberlain MC, Kormanik PA. AIDS-related central nervous system lymphomas. J Neurooncol 1999;43:269-276.
5. Cote TR, Manns A, Hardy CR, et al. Epidemiology of brain lymphoma among people with or without acquired immunodeficiency syndrome. AIDS/Cancer Study Group. J Natl Cancer Inst 1996;88:675-679.
6. Kirk O, Pedersen C, Cozzi-Lepri A, et al. Non-Hodgkins lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy. Blood 2001;98:3406-3412
7. Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults. J Natl Cancer Inst 2000;92:1823-1830.
8. Olson JE, Janney CA, Rao RD, et al. The continuing increase in the incidence of primary central nervous system non-hodgkins lymphoma: A surveillance, epidemiology, and end results analysis. Cancer 2002;95:1504-1510.
9. McGowan JP, Shah S. Long term remission of AIDS-related primary central nervous system lymphoma associated with highly active antiretroviral therapy. AIDS 1998;12:952-954.
10. Chotmongkol V, Pesee M. AIDS-related primary central nervous system lymphoma: prolonged remission associated with highly active antiretroviral therapy. J Med Assoc Thai 2002;85:634-637.
11. Corales R, Raege A. Regression of AIDS-related CNS lymphoma with HAART [abstract MoPpB1086]. XIII International AIDS Conference, 2000.
12. CDC Update. Acquired immunodeficiency syndrome - United States. MMWR, 1986:35:17-21.
13. Newell M, Hoy J. Human immunodeficiency virusrelated primary central nervous system lymphoma: factors influencing survival in 111 patients. Cancer 2004;100:2627-2636.
14. Hoffmann C, Tabrizian S et al. Survival of AIDS patients with primary central nervous system lymphoma is dramatically improved by HAART-induced immune recovery. AIDS 2001;15:2119-2127.
15. Thompson MP, Kurzrock R. Epstein-Barr virus and cancer. Clin Cancer Res 2004;10:803-821International Collaboration of HIV and Cancer. Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus infected adults. J Natl Cancer Inst 2000;92:1823-1830.
16. Ebrahim SH, Abdullah ASM, McKenna M, Hamers FF. AIDS-defining cancers in Western Europe. AIDS Patient Care and STDs 2004;18:501-508.
17. Thompson MP, Kurzrock R. Epstein-Barr virus and cancer. Clin Cancer Res 2004;10:803-821.
18. Bashir R, Luka J, Cheloha K, et al. Expression of Epstein-Barr virus proteins n primary central nervous system lymphoma in AIDS patients. Neurology 1993;43:2358-2362.
19. Aboulafia DM, Ratner L, Miles SA, et al. Antiviral and immunomodulatory treatment for AIDS-related primary central nervous system lymphoma: AIDS Malignancy Consortium Pilot Study 019. Clin Lymph Myeloma 2006;6:399-402.
20. Ling S, Roach M, Larson D, Wara W. Radiotherapy of primary central nervous system lymphoma in patients with and without human immunodeficiency virus. Cancer 1994;73:2570-2580.
21. Baumgartner J, Rachlin J et al. Primary central nervous system lymphomas: natural history and response to radiation therapy in 55 patients with acquired immunodeficiency syndrome. J Neurosurg 1990;73:206-211.
22. Keime-Guibert F, Napolitano M, Delattre KY. Neurological complications of radiotherapy and chemotherapy. J Neurol 1998;245:695-708.